| 000 | 01242 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250511235753.0 | ||
| 264 | 0 | _c19900912 | |
| 008 | 199009s 0 0 eng d | ||
| 022 | _a0008-5472 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTjuljandin, S A | |
| 245 | 0 | 0 |
_aPharmacokinetics and toxicity of two schedules of high dose epirubicin. _h[electronic resource] |
| 260 |
_bCancer research _cAug 1990 |
||
| 300 |
_a5095-101 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aBiotransformation |
| 650 | 0 | 4 | _aChromatography, High Pressure Liquid |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 |
_aEpirubicin _xadverse effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInjections, Intravenous |
| 650 | 0 | 4 |
_aLeukocyte Count _xdrug effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aPlatelet Count _xdrug effects |
| 700 | 1 | _aDoig, R G | |
| 700 | 1 | _aSobol, M M | |
| 700 | 1 | _aWatson, D M | |
| 700 | 1 | _aSheridan, W P | |
| 700 | 1 | _aMorstyn, G | |
| 700 | 1 | _aMihaly, G | |
| 700 | 1 | _aGreen, M D | |
| 773 | 0 |
_tCancer research _gvol. 50 _gno. 16 _gp. 5095-101 |
|
| 999 |
_c2385246 _d2385246 |
||